Business Wire

Quantum-Si Announces Presentation on the Use of Next-Generation Protein Sequencing™ to Detect Disease-Relevant Proteoforms at the Festival of Genomics and Biodata

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today ...
Yahoo Finance

Opna Bio Announces 2025 ASH Presentations Highlighting Preclinical Data from Novel Protein Degrader Program and Updated Interim Data from Phase 1 Combination Study of OPN-2853 ...

SOUTH SAN FRANCISCO, Calif., November 04, 2025--(BUSINESS WIRE)--Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics, announced ...
Seeking Alpha

C4 Therapeutics Announces Presentations and Participation in 7th Annual Targeted Protein Degradation & Induced Proximity Summit

Additional information about the 7 th Annual Targeted Protein Degradation & Induced Proximity Summit, including an overview for each of the above sessions, is available on the conference website.
TipRanks on MSN

Quantum-Si updates investor presentation highlighting proteomics strategy

Quantum-Si ( ($QSI) ) has provided an update. On December 29, 2025, Quantum-Si posted an updated corporate presentation for investors on its ...
Morningstar

Opna Bio Announces 2025 ASH Presentations Highlighting Preclinical Data from Novel Protein Degrader Program and Updated Interim Data from Phase 1 Combination Study of OPN-2853 ...

Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics, announced today that it will have an oral and a poster presentation at the ...